FR3104944B1 - Dendrimères à motifs thiophosphoramidate et dérivés - Google Patents

Dendrimères à motifs thiophosphoramidate et dérivés Download PDF

Info

Publication number
FR3104944B1
FR3104944B1 FR1915518A FR1915518A FR3104944B1 FR 3104944 B1 FR3104944 B1 FR 3104944B1 FR 1915518 A FR1915518 A FR 1915518A FR 1915518 A FR1915518 A FR 1915518A FR 3104944 B1 FR3104944 B1 FR 3104944B1
Authority
FR
France
Prior art keywords
thiophosphoramidate
derivatives
dendrimers
units
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1915518A
Other languages
English (en)
Other versions
FR3104944A1 (fr
Inventor
Abdelouahd Oukhrib
Julien Aujard-Catot
Rémy Poupot
Cédric-Olivier Turrin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Universite Toulouse III Paul Sabatier
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Universite Toulouse III Paul Sabatier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1915518A priority Critical patent/FR3104944B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS, Institut National de la Sante et de la Recherche Medicale INSERM, Universite Toulouse III Paul Sabatier filed Critical Centre National de la Recherche Scientifique CNRS
Priority to PCT/FR2020/052609 priority patent/WO2021130454A1/fr
Priority to EP20851329.1A priority patent/EP4081530A1/fr
Priority to US17/788,114 priority patent/US20240116963A1/en
Priority to AU2020414428A priority patent/AU2020414428A1/en
Priority to IL294253A priority patent/IL294253A/en
Priority to CN202080090104.XA priority patent/CN114867731B/zh
Priority to CA3165408A priority patent/CA3165408A1/fr
Publication of FR3104944A1 publication Critical patent/FR3104944A1/fr
Application granted granted Critical
Publication of FR3104944B1 publication Critical patent/FR3104944B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/65812—Cyclic phosphazenes [P=N-]n, n>=3
    • C07F9/65815—Cyclic phosphazenes [P=N-]n, n>=3 n = 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Dental Preparations (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Polyesters Or Polycarbonates (AREA)

Abstract

La présente concerne de nouveaux dendrimères à motifs thiophosphoramidate et dérivés, leur procédé de préparation et leur utilisation.
FR1915518A 2019-12-23 2019-12-23 Dendrimères à motifs thiophosphoramidate et dérivés Active FR3104944B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR1915518A FR3104944B1 (fr) 2019-12-23 2019-12-23 Dendrimères à motifs thiophosphoramidate et dérivés
EP20851329.1A EP4081530A1 (fr) 2019-12-23 2020-12-22 Dendrimères à motifs thiophosphoramidate et dérivés
US17/788,114 US20240116963A1 (en) 2019-12-23 2020-12-22 Dendrimers having thiophosphoramidate patterns and derivatives
AU2020414428A AU2020414428A1 (en) 2019-12-23 2020-12-22 Dendrimers having thiophosphoramidate patterns and derivatives
PCT/FR2020/052609 WO2021130454A1 (fr) 2019-12-23 2020-12-22 Dendrimères à motifs thiophosphoramidate et dérivés
IL294253A IL294253A (en) 2019-12-23 2020-12-22 Dendrimers containing thiophosphoramid groups and their uses
CN202080090104.XA CN114867731B (zh) 2019-12-23 2020-12-22 具有硫磷酰胺晶体结构的树枝状大分子及其衍生物
CA3165408A CA3165408A1 (fr) 2019-12-23 2020-12-22 Dendrimeres a motifs thiophosphoramidate et derives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1915518A FR3104944B1 (fr) 2019-12-23 2019-12-23 Dendrimères à motifs thiophosphoramidate et dérivés
FR1915518 2019-12-23

Publications (2)

Publication Number Publication Date
FR3104944A1 FR3104944A1 (fr) 2021-06-25
FR3104944B1 true FR3104944B1 (fr) 2022-01-07

Family

ID=70154597

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1915518A Active FR3104944B1 (fr) 2019-12-23 2019-12-23 Dendrimères à motifs thiophosphoramidate et dérivés

Country Status (8)

Country Link
US (1) US20240116963A1 (fr)
EP (1) EP4081530A1 (fr)
CN (1) CN114867731B (fr)
AU (1) AU2020414428A1 (fr)
CA (1) CA3165408A1 (fr)
FR (1) FR3104944B1 (fr)
IL (1) IL294253A (fr)
WO (1) WO2021130454A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2862651B1 (fr) 2003-11-24 2006-03-31 Rhodia Cons Spec Ltd Nouveaux dendrimeres a terminaisons bisphosphoniques et derives, leur procede de preparation et leur utilisation
US10106565B2 (en) * 2008-08-01 2018-10-23 Centre National De La Recherche Scientifique Phosphorylated dendrimers as antiinflammatory drugs
US20100173871A1 (en) 2008-08-01 2010-07-08 Centre National De La Recherche Scientifique Phosphorylated dendrimers as antiinflammatory drugs

Also Published As

Publication number Publication date
AU2020414428A1 (en) 2022-07-14
CA3165408A1 (fr) 2021-07-01
CN114867731A (zh) 2022-08-05
CN114867731B (zh) 2024-08-16
IL294253A (en) 2022-08-01
FR3104944A1 (fr) 2021-06-25
US20240116963A1 (en) 2024-04-11
WO2021130454A1 (fr) 2021-07-01
EP4081530A1 (fr) 2022-11-02

Similar Documents

Publication Publication Date Title
CY1125436T1 (el) Αναστολεις dna-pk
CY1123561T1 (el) Ενωσεις χρησιμες ως αναστολεις κινασης
MA46325B1 (fr) Composés dinucléotidiques cycliques
EA201891202A1 (ru) Композиции, содержащие бактериальные штаммы
EA201891201A1 (ru) Композиции, содержащие бактериальные штаммы
CY1118750T1 (el) Καινοφανη συντηγμενα παραγωγα πυριμιδινης για την αναστολη της δρασης της τυροσινικης κινασης
EA201890050A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890049A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890013A1 (ru) Способы получения tcr гамма дельтат-клеток
EA201891199A1 (ru) Композиции, содержащие бактериальные штаммы
MA45747A (fr) Génération de cellules bêta fonctionnelles à partir de progéniteurs endocrines dérivés de cellules souhes pluripotentes humaines
EA201890051A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890048A1 (ru) Композиции, содержащие бактериальные штаммы
EA201890047A1 (ru) Композиции, содержащие бактериальные штаммы
BR112017026586A2 (pt) composições de terapia de restauração de microbiota (mrt) e métodos de fabricação
EA202090291A3 (ru) Производные бипиразола в качестве ингибиторов jak
EA201591707A1 (ru) КОМПОЗИЦИИ иРНК КОМПОНЕНТА КОМПЛЕМЕНТА C5 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
CY1123231T1 (el) Ενωσεις τετραϋδροπυριμιδοδιαζεπινης και τετραϋδροπυριδοδιαζεπινης για θεραπεια πονου και καταστασεων σχετικων με τον πονο
CL2021002503A1 (es) Anticuerpos contra triptasa, composiciones de estos y usos de estos. (divisional de solicitud 201902251)
CL2017003147A1 (es) Moduladores de receptor nuclear
MD3728207T2 (ro) Chinazolinone ca inhibitori PARP14
ECSP17080733A (es) Anticuerpos dirigidos a la proteína morfogenética ósea 9 (bmp9) y métodos a partir de estos
BR112020015308A8 (pt) Proteínas f de rsv estabilizadas e usos das mesmas
CO2022002001A2 (es) Usos terapéuticos de anticuerpos anti-variable delta 1 de tcr
EA202190810A1 (ru) Способы и наборы для получения цельной крови с инактивированным патогеном

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20210625

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5